Literature DB >> 10666057

c-Myb modulates transcription of the alpha-smooth muscle actin gene in activated hepatic stellate cells.

M Buck1, D J Kim, K Houglum, T Hassanein, M Chojkier.   

Abstract

Expression of alpha-smooth muscle actin (alpha-SMA) defines the phenotype of activated (myofibroblastic) hepatic stellate cells. These cells, but not quiescent stellate cells, have a high level of alpha-SMA and c-Myb expression, as well as increased c-Myb-binding activities to the proximal alpha-SMA E box. Therefore, we analyzed the role of c-Myb in alpha-SMA transcription and stellate cell activation. Activated primary rat stellate cells displayed a high expression of the -724 and -271 alpha-SMA/luciferase (LUC) chimeric genes, which contain c-Myb binding sites (-223/-216 bp). Alpha-SMA/LUC minigenes with mutation (-219/-217 bp), truncation (-224 bp), or deletion (-191 bp) of the c-Myb binding site were not efficiently transcribed. Transfection of wild-type c-Myb into quiescent stellate cells, which do not express endogenous c-Myb, induced a approximately 10-fold stimulation of -724 alpha-SMA/LUC expression. Conversely, expression of either a dominant-negative c-Myb basic domain mutant (Cys(43) --> Asp) or a c-Myb antisense RNA blocked transcription from the -724 alpha-SMA/LUC or -271 alpha-SMA/LUC in activated cells. Moreover, transfection of c-myb antisense, but not sense, RNA inhibited both expression of the endogenous alpha-SMA gene and stellate cell activation, whereas transfection of c-myb stimulated alpha-SMA expression in quiescent stellate cells. These findings suggest that c-Myb modulates the activation of stellate cells and that integrity of the redox sensor Cys(43) in c-Myb is required for this effect.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666057     DOI: 10.1152/ajpgi.2000.278.2.G321

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  13 in total

Review 1.  Transcriptional regulation of hepatic stellate cell activation.

Authors:  D A Mann; D E Smart
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

Review 2.  Recent developments in myofibroblast biology: paradigms for connective tissue remodeling.

Authors:  Boris Hinz; Sem H Phan; Victor J Thannickal; Marco Prunotto; Alexis Desmoulière; John Varga; Olivier De Wever; Marc Mareel; Giulio Gabbiani
Journal:  Am J Pathol       Date:  2012-03-02       Impact factor: 4.307

3.  Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells.

Authors:  E Novo; F Marra; E Zamara; L Valfrè di Bonzo; A Caligiuri; S Cannito; C Antonaci; S Colombatto; M Pinzani; M Parola
Journal:  Gut       Date:  2005-07-24       Impact factor: 23.059

4.  Effects of c-myb antisense RNA on TGF-beta1 and beta1-I collagen expression in cultured hepatic stellate cells.

Authors:  Hui-Hui Ma; Ji-Lu Yao; Gang Li; Chun-Lan Yao; Xue-Juan Chen; Shao-Ji Yang
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

5.  Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis.

Authors:  Biao Hu; Mehrnaz Gharaee-Kermani; Zhe Wu; Sem H Phan
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

6.  Redox mechanisms in hepatic chronic wound healing and fibrogenesis.

Authors:  Erica Novo; Maurizio Parola
Journal:  Fibrogenesis Tissue Repair       Date:  2008-10-13

7.  Rho kinase inhibitors block activation of pancreatic stellate cells.

Authors:  Atsushi Masamune; Kazuhiro Kikuta; Mashiro Satoh; Kennichi Satoh; Tooru Shimosegawa
Journal:  Br J Pharmacol       Date:  2003-10-27       Impact factor: 8.739

8.  Suppressive effect of orthovanadate on hepatic stellate cell activation and liver fibrosis in rats.

Authors:  Yuji Nishikawa; Naoto Ohi; Akiko Yagisawa; Yuko Doi; Yohei Yamamoto; Masayuki Yoshida; Takuo Tokairin; Toshiaki Yoshioka; Yasufumi Omori; Katsuhiko Enomoto
Journal:  Am J Pathol       Date:  2009-01-22       Impact factor: 4.307

9.  Employment of gene expression profiling to identify transcriptional regulators of hepatic stellate cells.

Authors:  Hideaki Shimada; Lakshman E Rajagopalan
Journal:  Fibrogenesis Tissue Repair       Date:  2012-06-06

10.  Lipopolysaccharide Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against Decapentaplegic, and CCAAT/Enhancer-Binding Protein C/EBP Transcription Factors.

Authors:  Akanksha Sharma; Alok K Verma; Matthew Kofron; Ramesh Kudira; Alexander Miethke; Tong Wu; Jiang Wang; Chandrashekhar R Gandhi
Journal:  Hepatology       Date:  2020-10-22       Impact factor: 17.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.